Evidence map›Paper›PMID 38297204›Full record

SynthesisBMC ophthalmology2024

Prevalence of dry eye and Meibomian gland dysfunction in Central and South America: a systematic review and meta-analysis.

Hongan Chen, Paul McCann, Tiffany Lien, Mengli Xiao, Alison G Abraham, Darren G Gregory, Scott G Hauswirth, Riaz Qureshi, Su-Hsun Liu, Ian J Saldanha and 1 more

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in BMC ophthalmology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
11.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Hongan Chen *Department of Ophthalmology, University of Colorado Anschutz Medical Campus, 1675 Aurora Ct, Aurora, CO, F731, USA.
Paul McCann *Department of Ophthalmology, University of Colorado Anschutz Medical Campus, 1675 Aurora Ct, Aurora, CO, F731, USA.
Tiffany LienDepartment of Ophthalmology, University of Colorado Anschutz Medical Campus, 1675 Aurora Ct, Aurora, CO, F731, USA.
Mengli XiaoCenter for Innovative Design & Analysis, Colorado School of Public Health, Aurora, CO, USA.
Alison G AbrahamDepartment of Ophthalmology, University of Colorado Anschutz Medical Campus, 1675 Aurora Ct, Aurora, CO, F731, USA.
Darren G GregoryDepartment of Ophthalmology, University of Colorado Anschutz Medical Campus, 1675 Aurora Ct, Aurora, CO, F731, USA.
Scott G HauswirthDepartment of Ophthalmology, University of Colorado Anschutz Medical Campus, 1675 Aurora Ct, Aurora, CO, F731, USA.
Riaz QureshiDepartment of Ophthalmology, University of Colorado Anschutz Medical Campus, 1675 Aurora Ct, Aurora, CO, F731, USA.
Su-Hsun LiuDepartment of Ophthalmology, University of Colorado Anschutz Medical Campus, 1675 Aurora Ct, Aurora, CO, F731, USA.
Ian J SaldanhaDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Tianjing LiDepartment of Ophthalmology, University of Colorado Anschutz Medical Campus, 1675 Aurora Ct, Aurora, CO, F731, USA. tianjing.li@cuanschutz.edu.
University of Colorado Anschutz Medical Campus · USColorado School of Public Health · USJohns Hopkins University · US

Funding

Maximizing Use of High-Quality Evidence in Eye Care: Cochrane Eyes and Vision US ProjectUG1EY020522 · NEI · UNIVERSITY OF COLORADO DENVER · PI Tianjing Li · 2017 to 2026
$10.1M
NEI NIH HHS UG1 EY020522
6 · The paper itself

Abstract

backgroundDry eye is one of the most common ophthalmic conditions and can significantly impact quality of life. Meibomian gland dysfunction (MGD) is a major cause of evaporative dry eye. We sought to conduct a systematic review and meta-analysis to estimate the prevalence and incidence of dry eye and MGD in Central and South America and to identify factors associated with disease burden.

methodsData sources Ovid MEDLINE and Embase. STUDY SELECTION: A search conducted on August 16, 2021, identified studies published between January 1, 2010, and August 16, 2021, with no restrictions regarding participant age or language of publication. Case reports, case series, case-control studies, and interventional studies were excluded. DATA EXTRACTION AND SYNTHESIS: The review was based on a protocol registered on PROSPERO (CRD42021256934). Risk of bias was assessed in duplicate using a risk of bias tool designed for the purposes of descriptive epidemiological studies. Data were extracted by one investigator and verified by another for accuracy. Prevalence of dry eye and MGD were grouped based on study participant characteristics. MAIN OUTCOMES AND MEASURES: Prevalence and incidence of dry eye and MGD in Central and South America. Summary estimates from meta-analysis with 95% confidence intervals (CI).

resultsFourteen studies (11,594 total participants) were included. The population prevalence of dry eye was 13% (95% CI, 12%-14%) in Brazil and 41% (95% CI, 39%-44%) in Mexico based on one study each. Meta-analyses suggested that dry eye prevalence was 70% among indoor workers (95% CI, 56%-80%; I

conclusionsThis systematic review and meta-analysis demonstrated considerable variation in the published prevalence of dry eye and MGD among the general population and subpopulations in Central and South America. Local and subpopulation estimates of dry eye disease burden may be valuable to assist needs assessments and implementation of measures to mitigate the condition.

Indexed as

Dry Eye SyndromesMeibomian Gland DysfunctionBrazilHumansMeibomian GlandsPrevalenceQuality of LifeTearsCentral AmericaDry eye syndromeMeibomian gland diseaseMeta-analysisPrevalenceSouth America

Identifiers

PMID38297204
PMCPMC10829227
OpenAlexW4391387693

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.